{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:39:54Z","timestamp":1792611594596,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2449-y","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T10:04:15Z","timestamp":1556791455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["The global challenge of Candida auris in the intensive care unit"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-9993","authenticated-orcid":false,"given":"Andrea","family":"Cortegiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Misseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Giarratano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"2449_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40560-018-0342-4","volume":"6","author":"A Cortegiani","year":"2018","unstructured":"Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69.","journal-title":"J Intensive Care"},{"key":"2449_CR2","doi-asserted-by":"publisher","first-page":"e00578","DOI":"10.1002\/mbo3.578","volume":"7","author":"J Osei Sekyere","year":"2018","unstructured":"Osei Sekyere J. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. MicrobiologyOpen. 2018;7:e00578.","journal-title":"MicrobiologyOpen."},{"key":"2449_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/myc.12781","volume":"61","author":"A Ruiz-Gaitan","year":"2018","unstructured":"Ruiz-Gaitan A, Moret AM, Tasias-Pitarch M, Aleixandre-Lopez AI, Martinez-Morel H, Calabuig E, et al. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses. 2018;61:498\u2013505.","journal-title":"Mycoses."},{"issue":"4","key":"2449_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00134-018-5363-x","volume":"45","author":"Andrea Cortegiani","year":"2018","unstructured":"Cortegiani A, Misseri G, Chowdhary A. What's new on emerging resistant Candida species. Intensive Care Med. 2018. \n                    https:\/\/doi.org\/10.1007\/s00134-018-5363-x\n                    \n                  .","journal-title":"Intensive Care Medicine"},{"key":"2449_CR5","first-page":"43","volume":"7","author":"J Rhodes","year":"2018","unstructured":"Rhodes J, Abdolrasouli A, Farrer RA, Cuomo CA, Aanensen DM, Armstrong-James D, et al. Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. Emerg Microbes Infect. 2018;7:43.","journal-title":"Emerg Microbes Infect"},{"key":"2449_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis. 2017;64:134\u201340.","journal-title":"Clin Infect Dis"},{"key":"2449_CR7","doi-asserted-by":"crossref","unstructured":"Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, et al. Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob Agents Chemother. 2018;62:e00238-18.","DOI":"10.1128\/AAC.00238-18"},{"key":"2449_CR8","doi-asserted-by":"publisher","unstructured":"Madder H, Moir I, Moroney R, Butcher L, Newnham R, Sunderland M, et al. Multiuse patient monitoring equipment as a risk factor for acquisition of Candida auris. bioRxiv. 2017:149054. \n                    https:\/\/doi.org\/10.1101\/149054\n                    \n                  .","DOI":"10.1101\/149054"},{"key":"2449_CR9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa1714373","volume":"379","author":"DW Eyre","year":"2018","unstructured":"Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379:1322\u201331.","journal-title":"N Engl J Med"},{"key":"2449_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","volume":"23","author":"L Sherry","year":"2017","unstructured":"Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, et al. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis. 2017;23:328\u201331.","journal-title":"Emerg Infect Dis"},{"key":"2449_CR11","doi-asserted-by":"crossref","unstructured":"Kean R, McKloud E, Townsend EM, Sherry L, Delaney C, Jones BL, et al. The comparative efficacy of antiseptics against Candida auris biofilms. Int J Antimicrob Agents. 2018.","DOI":"10.1016\/j.ijantimicag.2018.05.007"},{"key":"2449_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fmicb.2018.00726","volume":"9","author":"TSN Ku","year":"2018","unstructured":"Ku TSN, Walraven CJ, Lee SA. Candida auris: disinfectants and implications for infection control. Front Microbiol. 2018;9:726.","journal-title":"Front Microbiol"},{"key":"2449_CR13","unstructured":"https:\/\/ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-candida-auris-healthcare-settings-europe\n                    \n                  . Accessed 20 Mar 2019."},{"key":"2449_CR14","unstructured":"https:\/\/www.who.int\/glass\/en\/\n                    \n                  . Accessed 20 Mar 2019."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2449-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T23:31:12Z","timestamp":1588289472000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2449"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2449-y","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"29 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AC is a member of the Advisory Board of Critical Care. GM and DE declare to have no competing interests. AG received grants, fees for educational presentation, and advisory board membership, without any relationship to the submitted work, from Pfizer, Merck Sharp, and Gilead. Outside the submitted work, MB has received funding for scientific advisory boards, travel and speaker honoraria from Angelini, AstraZeneca, Bayer, Biomerieux, Cidara, Cubist, Gilead, Pfizer, Melinta Therapeutics, Menarini, MSD, Nabriva, Paratek, Roche, Shionogi, Tetraphase, The Medicines Company and Astellas Pharma Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"150"}}